openPR Logo
Press release

Female Sterilization Procedures Market Outlook And Research Survey To 2023

05-23-2017 03:53 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Female Sterilization Procedures Market Outlook And Research

Female sterilization procedure is a permanent way of preventing women from conceiving and acts as a form of birth control and is the most commonly used family planning method used across the globe. It is an out-patient procedure performed in hospitals, clinical or doctor’s office. Complications post procedures are very rare and include bowel or bladder injury, infection, problems related to anesthesia and internal bleeding. Intensive research has been conducted in order to find the most ideal option for birth control. High efficacy, easy accessibility to the procedure, and cultural acceptability are the major criteria for the determination of ideal family planning method. In addition, it is often demanded that the method should be simple, easily learned, quick and should be able to be performed in outpatient setting without anesthesia.

Browse through Female Sterilization Procedures Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/female-sterilization-procedures-market.html

The global female sterilization procedures market can be segmented based on procedure type and geography. Geographically, the global female sterilization procedures market can be categorized into four major regions namely North America, Europe, Asia Pacific and Rest of the World. Procedures are further classified as surgical and non-surgical sterilization. Surgical approach involves cutting (tubal ligation), tying (with clamps, clips or rings) or sealing (with the help of electric current) of the fallopian tubes while non surgical method involves blocking of the fallopian tubes with the help of tiny spring like coils. On non-surgical insertion, these tiny devices evoke formation of scar tissue thus blocking the fallopian tube. The blockage of tubes is confirmed with X-ray after few months. Various procedures include hysteroscopic (no-incision) method, high risk method such as hysterectomy and incision methods comprising laparoscopy, laparotomy and mini-laparotomy.

A hysterescope inserted into the uterus through the vagina and cervix, allows direct visualization of the tubal ostia and endometrial cavity. Hysteroscopic sterilization is found to potentially fulfil majority of the criteria. However, advent of minimally invasive birth control methods such as transcervical sterilization procedures, implantation of intra-uterine devices, sub dermal contraceptives and others has resulted into decline in demand for hysteroscopic sterilization in women. Laparotomy is less commonly used procedure when compared to the commonly used laparoscopy and mini laparotomy. Technological development in the optics, video technology, illumination and instrumentation has extended the scope of laparoscopy in gynecology. Moreover, this procedure allows minimal recovery time, less risk of contracting infection and overall improvement in patient care.

Get accurate market forecast and analysis on the Female Sterilization Procedures Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6871

Increase in the awareness of the device and procedure by direct-to-consumer advertising with the help of radio, internet, TV, and print media may boost the unit sales. Certain drawbacks associated with female sterilization procedures are that these do not provide protection against sexually transmitted diseases (STDs) and also possess risk of infection, bleeding and pain. The Essure system by Conceptus, Inc. (a subsidiary of Bayer Healthcare) is a novel method of permanent female sterilization. It can be performed in office setting and involves implantation of a small metallic structure into the fallopian tubes of the patient willing to be permanently sterilized. This implant works by creating a scar tissue over it thus blocking the fallopian tube and preventing egg fertilization. A similar system known as Adiana system developed by Hologic, Inc. was introduced in the market which involved use of silicone implant. However, the Adiana system has been discontinued in the market by the company.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Female Sterilization Procedures Market Outlook And Research Survey To 2023 here

News-ID: 547701 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Female

Author Sananda Allsgood Releases New Female / Female Romance – The Awakening o …
Author Sananda Allsgood Releases New Female / Female Romance – The Awakening of Rae Author Sananda Allsgood is pleased to announce the release of his new Female / Female Romance novel, The Awakening of Rae. This is the first book in his The Rae Series. Rae came from a conservative, religious family and lived that life until her husband, Frank, was sent to Afghanistan for nine months. Looking
Female Condoms Market Professional Analysis Report 2019| Okamoto, Trojan, Ansell …
Los Angeles, United State, June 13, 2019, - The global Female Condoms market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global
Comprehensions on the Female Condoms Market - Top Players: Durex, Okamoto, Troja …
HTF MI recently introduced Global Female Condoms Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Durex, Okamoto, Trojan, Ansell, The Female Health Company, Sagami, Gulin Latex,
Female Infertility-Pipeline Insights, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Female Infertility-Pipeline Insights, 2017 “Female Infertility-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Female Infertility. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III
Top Five Manufacturers of Female Condoms Who are Leading the Global Female Condo …
Condoms are barrier-type contraceptives that are designed to eliminate the actual contact between sexual organs. They contain a physical barrier that stops the transfer of sexual fluids required for copulation. The introduction of female condoms has created a new segment in the global condom market. Although the adoption of these condoms is still in the nascent stage, the market offers a significant scope for the growth. Female condoms are contraceptive
Female Condom To Be The Next Big Wave in Female Contraceptive
Beige Market Intelligence has recently published an in-depth market research report on the Global Condom Market. The report highlights many vital information of which one is the adoption of female condom as a method of contraceptive. The driving forces and challenges while adoption of female condom. The report shows that female condom is like to grow at a faster rate than male condom. To know more about the report, please click